Advertisement

Pediatric Surgery International

, Volume 35, Issue 1, pp 9–14 | Cite as

Abnormal Scn1b and Fxyd1 gene expression in the pulled-through ganglionic colon may influence functional outcome in patients with Hirschsprung’s disease

  • Anne Marie O’Donnell
  • Hiroki Nakamura
  • Christian Tomuschat
  • Naoum Fares Marayati
  • Prem PuriEmail author
Original Article
  • 64 Downloads

Abstract

Purpose

Smooth muscle cells are electrically coupled to ICC and PDGFRα+ cells, to regulate smooth muscle contraction. Recent studies have reported that the voltage-gated sodium channel type 1β (Scn1b), and the chloride channel subunit, Fxyd1, are highly expressed by both ICC and PDGFRα+ cells in the mouse colon. We designed this study to investigate the expression of the Scn1b and Fxyd1 genes in the normal human colon and in HSCR.

Methods

HSCR tissue specimens (n = 6) were collected at the time of pull-through surgery, while control samples were obtained at the time of colostomy closure in patients with imperforate anus (n = 6). qRT-PCR analysis was undertaken to quantify Scn1b and Fxyd1 gene expression, and immunolabelling of Scn1b and Fxyd1 proteins were visualized using confocal microscopy.

Results

qRT-PCR analysis revealed significant downregulation of Scn1b and Fxyd1 genes in both aganglionic and ganglionic HSCR specimens compared to controls (p < 0.05). Confocal microscopy revealed a reduction in Scn1b and Fxyd1 protein expression in both aganglionic and ganglionic HSCR colon compared to controls.

Conclusion

Scn1b and Fxyd1 expression was significantly downregulated in HSCR colon. These results add to mounting evidence suggesting that the pulled-through ganglionic segment of bowel in these patients is abnormal, despite the presence of ganglion cells.

Keywords

Scn1b Fxyd1 ICC PDGFRα+ cells Hirschsprung’s disease 

References

  1. 1.
    Edokobi N, Isom LL (2018) Voltage-gated sodium channel β1/β1B subunits regulate cardiac physiology and pathophysiology. Front Physiol 9:351.  https://doi.org/10.3389/fphys.2018.00351 CrossRefGoogle Scholar
  2. 2.
    Franzin CM, Gong XM, Teriete P, Marassi FM (2007) Structures of the FXYD regulatory proteins in lipid micelles and membranes. J Bioenerg Biomembr 39(5–6):379–383.  https://doi.org/10.1007/s10863-007-9105-y CrossRefGoogle Scholar
  3. 3.
    Rolle U, Piotrowska AP, Nemeth L, Puri P (2002) Altered distribution of interstitial cells of Cajal in Hirschsprung disease. Arch Pathol Lab Med 126(8):928–933.  https://doi.org/10.1043/0003-9985(2002)126%3C0928:ADOICO%3E2.0.CO;2 Google Scholar
  4. 4.
    Coyle D, O’Donnell AM, Puri P (2015) Altered distribution of small-conductance calcium-activated potassium channel SK3 in Hirschsprung’s disease. J Pediatr Surg.  https://doi.org/10.1016/j.jpedsurg.2015.01.013 Google Scholar
  5. 5.
    O’Donnell A, Coyle D, Puri P (2016) Deficiency of platelet-derived growth factor receptor-α-positive cells in Hirschsprung’s disease colon. World J Gastroenterol 22(12):3335–3340CrossRefGoogle Scholar
  6. 6.
    Young HM, Bergner AJ, Anderson CR, Enomoto H, Milbrandt J, Newgreen DF, Whitington PM (2004) Dynamics of neural crest-derived cell migration in the embryonic mouse gut. Dev Biol 270:455–473CrossRefGoogle Scholar
  7. 7.
    O’Donnell AM, Coyle D, Puri P (2015) Decreased expression of hyperpolarisation-activated cyclic nucleotide-gated channel 3 in Hirschsprung’s disease. World J Gastroenterol 21(18):5635–5640.  https://doi.org/10.3748/wjg.v21.i18.5635 CrossRefGoogle Scholar
  8. 8.
    Rolle U, Nemeth L, Puri P (2002) Nitrergic innervation of the normal gut and in motility disorders of childhood. J Pediatr Surg 37(4):551–567CrossRefGoogle Scholar
  9. 9.
    Menezes M, Corbally M, Puri P (2006) Long-term results of bowel function after treatment for Hirschsprung’s disease: a 29-year review. Pediatr Surg Int 22(12):987–990.  https://doi.org/10.1007/s00383-006-1783-8 CrossRefGoogle Scholar
  10. 10.
    Menezes M, Prato AP, Jasonni V, Puri P (2008) Long-term clinical outcome in patients with total colonic aganglionosis: a 31-year review. J Pediatr Surg 43(9):1696–1699.  https://doi.org/10.1016/j.jpedsurg.2008.01.072 CrossRefGoogle Scholar
  11. 11.
    Mc Laughlin D, Friedmacher F, Puri P (2012) Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome. Pediatr Surg Int 28(8):773–779CrossRefGoogle Scholar
  12. 12.
    Yao H, Fan J, Cheng YJ, Chen XM, Ji CC, Liu LJ, Zheng ZH, Wu SH (2018) SCN 1Bβ mutations that affect their association with Kv4.3 underlie early repolarization syndrome. J Cell Mol Med.  https://doi.org/10.1111/jcmm.13839 Google Scholar
  13. 13.
    Watanabe H, Darbar D, Kaiser DW, Jiramongkolchai K, Chopra S, Donahue BS, Kannankeril PJ, Roden DM (2009) Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2(3):268–275.  https://doi.org/10.1161/CIRCEP.108.779181 CrossRefGoogle Scholar
  14. 14.
    Geering K (2005) Function of FXYD proteins, regulators of Na, K-ATPase. J Bioenerg Biomembr 37(6):387–392.  https://doi.org/10.1007/s10863-005-9476-x CrossRefGoogle Scholar
  15. 15.
    Floyd RV, Wray S, Martin-Vasallo P, Mobasheri A (2010) Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays. Ann Anat 192(1):7–16.  https://doi.org/10.1016/j.aanat.2009.09.003 CrossRefGoogle Scholar
  16. 16.
    Lee MY, Ha SE, Park C, Park PJ, Fuchs R, Wei L, Jorgensen BG, Redelman D, Ward SM, Sanders KM, Ro S (2017) Transcriptome of interstitial cells of Cajal reveals unique and selective gene signatures. PLoS One 12(4):e0176031.  https://doi.org/10.1371/journal.pone.0176031 CrossRefGoogle Scholar
  17. 17.
    Ha SE, Lee MY, Kurahashi M, Wei L, Jorgensen BG, Park C, Park PJ, Redelman D, Sasse KC, Becker LS, Sanders KM, Ro S (2017) Transcriptome analysis of PDGFRα+ cells identifies T-type Ca2+ channel CACNA1G as a new pathological marker for PDGFRα+ cell hyperplasia. PLoS One 12(8):e0182265.  https://doi.org/10.1371/journal.pone.0182265 CrossRefGoogle Scholar
  18. 18.
    Burns AJ, Goldstein AM, Newgreen DF, Stamp L, Schafer KH, Metzger M, Hotta R, Young HM, Andrews PW, Thapar N, Belkind-Gerson J, Bondurand N, Bornstein JC, Chan WY, Cheah K, Gershon MD, Heuckeroth RO, Hofstra RM, Just L, Kapur RP, King SK, McCann CJ, Nagy N, Ngan E, Obermayr F, Pachnis V, Pasricha PJ, Sham MH, Tam P, Vanden Berghe P (2016) White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies. Dev Biol 417(2):229–251.  https://doi.org/10.1016/j.ydbio.2016.04.001 CrossRefGoogle Scholar
  19. 19.
    Stamp LA, Young HM (2017) Recent advances in regenerative medicine to treat enteric neuropathies: use of human cells. Neurogastroenterol Motil.  https://doi.org/10.1111/nmo.12993 Google Scholar
  20. 20.
    McCann CJ, Thapar N (2018) Enteric neural stem cell therapies for enteric neuropathies. Neurogastroenterol Motil.  https://doi.org/10.1111/nmo.13369 Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Anne Marie O’Donnell
    • 1
  • Hiroki Nakamura
    • 1
  • Christian Tomuschat
    • 1
  • Naoum Fares Marayati
    • 2
  • Prem Puri
    • 1
    Email author
  1. 1.National Children’s Research Centre, Our Lady’s Children’s Hospital CrumlinDublin 12Ireland
  2. 2.Department of PsychologyPrinceton UniversityPrincetonUSA

Personalised recommendations